Race Hots Up For EMA After Brexit
Executive Summary
France has officially named Lille as the city it would like to host the European Medicines Agency once the UK leaves the EU, and Italy has appointed an ambassador to promote Milan’s bid for the agency. Meanwhile, stakeholders in Denmark are joining forces to stress why Copenhagen would be a good choice, and Ireland, the Netherlands and Austria have all confirmed their candidacies.
You may also be interested in...
Quest For ‘It Factor’ Continues In Competition For EMA After Brexit
The many cities that want to host the European Medicines Agency when it moves from London to another member state in light of Brexit are working hard to come up with a determining factor that will make them the obvious choice. It may on the surface seem strange, but Ireland is making much of the fact that if its capital city Dublin were chosen, existing EMA staff wouldn’t need to move there.
Rasi On Brexit: ‘EMA Is Well-Oiled Machine That We Cannot Afford To Start Stuttering’
European Medicines Agency head Guido Rasi tackles issue of Brexit in agency’s 2016 annual report, saying EMA is “core building block of the common market for medicines in the EU” that operates like “well-oiled machinery.”
Ireland Promotes Dublin As ‘Natural Destination For EMA’ After Brexit
Ireland is promoting Dublin as the new natural home of the European Medicines Agency when the agency relocates from London after Brexit. It cites the “excellent existing relationship” the country’s regulator, the HPRA, has with the EMA and with the broader EU medicines regulatory network, and the fact that the HPRA doesn’t only regulate medicines.